142 related articles for article (PubMed ID: 19966213)
1. CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice.
Oracki SA; Tsantikos E; Quilici C; Light A; Schmidt T; Lew AM; Martin JE; Smith KG; Hibbs ML; Tarlinton DM
J Immunol; 2010 Jan; 184(2):757-63. PubMed ID: 19966213
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.
Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML
J Immunol; 2010 Feb; 184(3):1348-60. PubMed ID: 20042579
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene.
Moon BG; Takaki S; Nishizumi H; Yamamoto T; Takatsu K
Cell Immunol; 2004 Apr; 228(2):110-8. PubMed ID: 15219462
[TBL] [Abstract][Full Text] [Related]
5. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.
Mihara M; Tan I; Chuzhin Y; Reddy B; Budhai L; Holzer A; Gu Y; Davidson A
J Clin Invest; 2000 Jul; 106(1):91-101. PubMed ID: 10880052
[TBL] [Abstract][Full Text] [Related]
6. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency.
Verhagen AM; Wallace ME; Goradia A; Jones SA; Croom HA; Metcalf D; Collinge JE; Maxwell MJ; Hibbs ML; Alexander WS; Hilton DJ; Kile BT; Starr R
J Immunol; 2009 Feb; 182(4):2020-9. PubMed ID: 19201855
[TBL] [Abstract][Full Text] [Related]
7. Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig.
Chu EB; Hobbs MV; Wilson CB; Romball CG; Linsley PS; Weigle WO
J Immunol; 1996 Feb; 156(3):1262-8. PubMed ID: 8558006
[TBL] [Abstract][Full Text] [Related]
8. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.
Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML
J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
10. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice.
Hua Z; Gross AJ; Lamagna C; Ramos-Hernández N; Scapini P; Ji M; Shao H; Lowell CA; Hou B; DeFranco AL
J Immunol; 2014 Feb; 192(3):875-85. PubMed ID: 24379120
[TBL] [Abstract][Full Text] [Related]
11. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.
Lau M; Tsantikos E; Maxwell MJ; Tarlinton DM; Anderson GP; Hibbs ML
J Autoimmun; 2012 Dec; 39(4):388-97. PubMed ID: 22867713
[TBL] [Abstract][Full Text] [Related]
12. Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice.
Tsantikos E; Quilici C; Harder KW; Wang B; Zhu HJ; Anderson GP; Tarlinton DM; Hibbs ML
J Immunol; 2009 Aug; 183(4):2484-94. PubMed ID: 19620313
[TBL] [Abstract][Full Text] [Related]
13. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.
Gutierrez T; Mayeux JM; Ortega SB; Karandikar NJ; Li QZ; Rakheja D; Zhou XJ; Satterthwaite AB
Eur J Immunol; 2013 Feb; 43(2):382-93. PubMed ID: 23169140
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice.
Zhou YB; Ye RG; Li YJ; Xie CM; Wu YH
Autoimmunity; 2008 Aug; 41(5):395-404. PubMed ID: 18568645
[TBL] [Abstract][Full Text] [Related]
15. B cell-specific loss of Lyn kinase leads to autoimmunity.
Lamagna C; Hu Y; DeFranco AL; Lowell CA
J Immunol; 2014 Feb; 192(3):919-28. PubMed ID: 24376269
[TBL] [Abstract][Full Text] [Related]
16. MyD88-dependent autoimmune disease in Lyn-deficient mice.
Silver KL; Crockford TL; Bouriez-Jones T; Milling S; Lambe T; Cornall RJ
Eur J Immunol; 2007 Oct; 37(10):2734-43. PubMed ID: 17853409
[TBL] [Abstract][Full Text] [Related]
17. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease.
Hibbs ML; Tarlinton DM; Armes J; Grail D; Hodgson G; Maglitto R; Stacker SA; Dunn AR
Cell; 1995 Oct; 83(2):301-11. PubMed ID: 7585947
[TBL] [Abstract][Full Text] [Related]
18. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Yajima K; Nakamura A; Sugahara A; Takai T
Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
[TBL] [Abstract][Full Text] [Related]
19. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.
Nishizumi H; Taniuchi I; Yamanashi Y; Kitamura D; Ilic D; Mori S; Watanabe T; Yamamoto T
Immunity; 1995 Nov; 3(5):549-60. PubMed ID: 7584145
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous class switching and B cell hyperactivity increase autoimmunity against intracellular self antigen in Lyn-deficient mice.
Silver K; Bouriez-Jones T; Crockford T; Ferry H; Tang HL; Cyster JG; Cornall RJ
Eur J Immunol; 2006 Nov; 36(11):2920-7. PubMed ID: 17039569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
